Episode
Garmin Goes Screenless, Kalshi Predicts Drug Trials, Coffee Gets a Green Light
- Podcast
- Fitt Insider
- Published
- Jul 22, 2026
- Duration seconds
- 147
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/fitt-insider-254580/episodes/garmin-goes-screenless-kalshi-predicts-drug-trials-coffee-gets-a-green-light/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/fitt-insider-254580/garmin-goes-screenless-kalshi-predicts-drug-trials-coffee-gets-a-green-light.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
July 22, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Garmin launches CIRQA Smart Band, a screenless, subscription-free wearable, as hardware becomes table stakes and data interpretation becomes the real battleground Kalshi partners with AppliedXL to launch prediction markets forecasting clinical trial outcomes and FDA decisions, making drug development probabilities tradable American Heart Association guidance finds up to 400mg of caffeine daily is safe for most adults and may reduce heart disease risk, while warning on energy shots More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → [email protected]